
Mapime 1gm Injection
Marketer
Mapra Laboratories Pvt Ltd
Salt Composition
Cefepime (1gm)
Overview Mapime 1gm Injection
Cefoperazone 1g injection is a powerful antibacterial agent effective against a wide range of bacteria. It's indicated for severe infections affecting the skin, respiratory system, gastrointestinal tract, urinary system, and bloodstream. Its mechanism involves bacterial cell destruction. Importantly, it's ineffective against viral infections. This medication is frequently administered to critically ill hospitalized patients. Intravenous delivery, either by infusion or direct injection, is essential, always under medical or nursing supervision. Dosage is tailored to the infection's type, location, and severity. Continue the prescribed treatment course, even with rapid symptom improvement; premature discontinuation risks relapse or exacerbation. Adverse reactions, such as skin rash, pruritus, nausea, emesis, cephalgia, pyrexia, diarrhea, or localized injection site erythema and edema, may occur. These are usually transient, resolving with continued therapy. Report persistent or troublesome side effects to your physician. Prior to commencing treatment, disclose any renal or hepatic impairment, or antibiotic allergies. Regular blood tests to monitor renal function may be recommended during therapy. Generally, this medication is considered safe for pregnant and breastfeeding individuals under strict medical guidance.
Primary Ingredients of Mapime 1gm Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Mapime 1gm Injection
Managing life-threatening bacterial infections
Major Benefits of Mapime 1gm Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Mapime 1gm Injection:
- Injection site reactions (pain, swelling, redness)
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
- Increased prothrombin time
- Decreased phosphate level in blood
- Increased partial thromboplastin time (PTT)
How to use Mapime 1gm Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Mapime 1gm Injection works:
Mapime 1g injection is a bactericidal antibiotic that works by disrupting bacterial cell wall synthesis, a crucial process for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Mapime 1gm Injection and alcohol presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Administering Mapime 1gm Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; clinical data in humans, however, remain scarce.
Breast feedingSAFE IF PRESCRIBED
Mapime 1gm Injection poses minimal risk during lactation. Research in humans indicates negligible transfer into breast milk, posing no apparent threat to the infant. However, extended Mapime 1gm Injection use should be avoided due to potential side effects including skin rashes and diarrhea.
DrivingCONSULT YOUR DOCTOR
The effect of Mapime 1gm Injection on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Mapime 1gm Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Mapime 1gm Injection appears to be safely administered to individuals with hepatic impairment. Current evidence indicates dose modification for Mapime 1gm Injection may be unnecessary in this population; however, medical consultation is recommended.
What if you forget to take Mapime 1gm Injection :
Omit a Mapime 1gm Injection dose? Seek medical advice immediately.
Facts to Know About Mapime 1gm Injection
| Label | Value |
|---|---|
| Chemical Type | Cephalosporins (third and fourth generation) |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Actions | Fourth-Generation Cephalosporins |
